MAIA Biotechnology, Inc. (NYSEAMERICAN:MAIA – Get Free Report) shares were down 3.4% on Thursday . The company traded as low as $2.36 and last traded at $2.57. Approximately 120,695 shares changed hands during trading, a decline of 59% from the average daily volume of 292,118 shares. The stock had previously closed at $2.66.
MAIA Biotechnology Price Performance
The company has a market capitalization of $60.01 million, a PE ratio of -1.54 and a beta of 0.31.
MAIA Biotechnology (NYSEAMERICAN:MAIA – Get Free Report) last released its quarterly earnings data on Friday, August 9th. The company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.33) by $0.16. On average, equities analysts anticipate that MAIA Biotechnology, Inc. will post -1.25 earnings per share for the current fiscal year.
Institutional Trading of MAIA Biotechnology
About MAIA Biotechnology
MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.
Further Reading
- Five stocks we like better than MAIA Biotechnology
- High Flyers: 3 Natural Gas Stocks for March 2022
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- Basic Materials Stocks Investing
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
- 3 Fintech Stocks With Good 2021 Prospects
- MarketBeat Week in Review – 10/21- 10/25
Receive News & Ratings for MAIA Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAIA Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.